Naturally-occurring mutations such as K255E, T259I and S262P ACTN4 cause focal segmental glomerulosclerosis (FSGS) in affected humans because of their elevated actin binding activities13. Here, ACTN4 is linked to focal segmental glomerulosclerosis.